Pro-Dex (NASDAQ:PDEX) Releases Earnings Results, Beats Expectations By $0.11 EPS

Pro-Dex (NASDAQ:PDEX) announced its quarterly earnings results on Thursday. The medical instruments supplier reported $0.46 EPS for the quarter, topping the consensus estimate of $0.35 by $0.11, Yahoo Finance reports. The business had revenue of $15.03 million for the quarter. Pro-Dex had a return on equity of 6.50% and a net margin of 4.13%.

Pro-Dex Trading Up 4.6 %

Shares of PDEX traded up $1.03 on Friday, hitting $23.28. 26,474 shares of the stock traded hands, compared to its average volume of 8,070. The firm has a market capitalization of $79.62 million, a P/E ratio of 40.14 and a beta of 0.38. The company has a quick ratio of 2.08, a current ratio of 3.45 and a debt-to-equity ratio of 0.25. Pro-Dex has a 1 year low of $14.51 and a 1 year high of $24.74. The stock’s 50 day moving average is $19.73 and its two-hundred day moving average is $18.85.

Insider Buying and Selling at Pro-Dex

In related news, Director Angelita Rebamontan Domingo sold 2,585 shares of the stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $18.30, for a total transaction of $47,305.50. Following the transaction, the director now directly owns 8,191 shares in the company, valued at $149,895.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 42.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Pro-Dex from a “buy” rating to a “strong-buy” rating in a research note on Saturday.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.